Effects of primidone: A Synthesis of Findings from 26 Studies
- Home
- Effects of primidone
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of primidone: A Synthesis of Findings from 26 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Main Research Findings
Primidone is a commonly used anti-seizure medication. Many studies have investigated the effectiveness and safety of primidone. 21 analyzed the association between antiseizure medication (ASM) and the risk of urinary tract infections (UTI) in patients with epilepsy treated in general practices in Germany. 18 compared the safety of antiepileptic drugs (AEDs) on neurodevelopment of infants/children exposed in utero or during breast feeding. 9 quantified recent reports of DILI attributed to both older and newer generation ASMs and surveyed newly marketed ASMs for hepatotoxicity in a large post-marketing database. 11 discussed the reduction of neuronal hyperexcitability with modulation of T-type calcium channel or SK channel in essential tremor. 19 reviewed the literature and pharmacovigilance databases for pitch perception modifications due to antiepileptics. 24 evaluated pregabalin for essential tremor. 6 presented data on phenylethylmalonamide (PEMA) serum levels in patients treated with primidone and the effects of other antiepileptic drugs. 4 investigated ozone-based advanced oxidation processes for primidone removal in water using simulated solar radiation. 12 described pharmacologic considerations during the preoperative evaluation of neurologic patients. 15 evaluated prescribing patterns for potentially teratogenic AEDs and contraceptive use in women of childbearing ability with epilepsy. 3 reported a unique case of transiently elevated liver function test (LFT) values associated with concurrent use of dabigatran and primidone. 13 demonstrated that primidone blocks RIPK1-driven cell death and inflammation. 1 discussed the proliferation of the gingiva as an adverse effect of medications. 5 provided information and preliminary guidance related to the FDA Emergency Use Authorization for Paxlovid™ for the oral treatment of mild to moderate COVID-19 in adults and children. 10 addressed the current management of essential tremor. 26 measured the levels of 19 commonly occurring pharmaceutical and personal care products (PPCPs) in 8 vegetables irrigated with treated wastewater under field conditions. 14 provided insights into current and future pharmacotherapeutic approaches for essential tremor. reported a possible interaction of rivaroxaban with primidone in a patient with atrial fibrillation. 17 showed that Dupuytren, Ledderhose, and Peyronie diseases have been associated with antiepileptic drug use. 16 discussed epilepsy and breastfeeding. 25 aimed to synthesize emerging evidence for oral propranolol on subgroups of ET. examined the rate of onset of side effects in pediatric outpatients who received long-term monotherapy with phenobarbital (PB), primidone (PRM), phenytoin (PHT), carbamazepine (CBZ), or valproate (VPA). 23 evaluated a recirculating hydroponic bed bioreactor for removal of contaminants of emerging concern from tertiary-treated wastewater effluent. 8 conducted a synoptic survey of select wastewater-tracer compounds and the pesticide imidacloprid in Florida's ambient freshwaters. 7 reported a case of phenytoin induced dystonia. 20 systematically investigated the transport mechanisms of organic micropollutants (OMPs) in a fertilizer-drawn forward osmosis (FDFO) membrane process. studied the effects of withdrawing phenytoin, phenobarbital and primidone, and using carbamazepine as the primary anticonvulsant in 27 patients.
Benefits and Risks
Benefit Summary
Primidone has been shown to be effective in treating seizures. found that seizure control was essentially similar or somewhat improved in 20 out of 21 patients who received carbamazepine instead of sedative anticonvulsants, including primidone. 10 recommended primidone alongside propranolol for the treatment of essential tremor. 11 suggested that primidone might be effective in reducing neuronal hyperexcitability. 13 demonstrated that primidone blocks RIPK1-driven cell death and inflammation.
Risk Summary
Primidone carries some risk of side effects. 9 found that primidone could cause drug-induced liver injury (DILI). 17 reported that Dupuytren, Ledderhose, and Peyronie diseases have been associated with antiepileptic drug use, including primidone. 1 suggested that primidone might cause gingival hyperplasia. 5 stated that concomitant use of Paxlovid™ with primidone is contraindicated due to potential drug interactions.
Comparison of Studies
Similarities in Studies
Many studies have suggested that primidone is effective in treating seizures and essential tremor. It has also been commonly reported to have some risk of side effects. However, the specific risk and severity of side effects vary across studies.
Differences in Studies
Different studies have shown primidone to be most effective in treating different diseases or conditions, and have shown varying levels of risk for side effects. For example, found that seizure control was improved in 20 out of 21 patients who received carbamazepine instead of primidone. However, 10 recommended primidone alongside propranolol for the treatment of essential tremor. These studies show that primidone can be effective in treating different conditions.
Consistency and Contradictions in Results
There is both consistency and contradiction in the results regarding the effectiveness and safety of primidone. Some studies show that primidone is effective in treating certain conditions, while others have shown that it can cause side effects. These inconsistencies may be explained by factors such as study design, subject population, and dosage. Further research is needed to clarify these inconsistencies.
Considerations for Real-Life Applications
It is important to take primidone as directed by your doctor. Do not stop taking it or adjust the dosage without consulting your doctor. If you have any concerns about side effects, talk to your doctor. If you are pregnant or breastfeeding, consult with your doctor about the use of primidone. Primidone may interact with other medications, so it is important to talk to your doctor before taking it. 5 indicates that concurrent use of Paxlovid™ with primidone is contraindicated. Because primidone is metabolized by the liver, it's important to consult your doctor if you have liver problems.
Limitations of Current Research
There are limitations in the research on primidone. For example, many studies have a small sample size, which could limit the generalizability of their results. Additionally, variations in study design and methodology make it challenging to compare results across studies.
Future Research Directions
Further research on primidone is needed. In particular, studies investigating the long-term effects of primidone on effectiveness and safety are important. Research is also needed to develop methods for reducing side effects and to investigate interactions between primidone and other medications. Furthermore, research on the potential of primidone for treating inflammatory diseases, as suggested by 13 , is warranted.
Conclusion
Primidone is a potential treatment for seizures and essential tremor. However, it is associated with the risk of side effects. If you are considering taking primidone, consult with your doctor to determine if it is the right treatment for you. It is important to take primidone under the care of a healthcare professional.
Benefit Keywords
Risk Keywords
Article Type
Author: de BaatC, ZweersP G M A, VissinkA
Language : Dutch
Author: HerranzJ L, ArmijoJ A, ArteagaR
Language : English
Author: CavinessLisa A, WassellKatelyn M, Howard-ThompsonAmanda
Language : English
Author: FigueredoManuel A, RodríguezEva M, ChecaManuel, BeltranFernando J
Language : English
Author: CokleyJon A, GidalBarry E, KellerJoy A, VosslerDavid G,
Language : English
Author: StreeteJ M, BerryD J, PettitL I, NewberyJ E
Language : English
Author: AcarTarık, AlkanGülsüm, ÇaksenHüseyin, ErtekinBirsen, ErginMehmet, KoçakSedat, CanderBaşar
Language : English
Author: SilvanimaJames, WoeberAndy, Sunderman-BarnesStephanie, CopelandRick, SedlacekChristopher, SealThomas
Language : English
Author: KamitakiBrad K, MinacapelliCarlos D, ZhangPengfei, WachukuChristopher, GuptaKapil, CatalanoCarolyn, RustgiVinod
Language : English
Author: SharmaSoumya, PandeySanjay
Language : English
Author: Wagle ShuklaAparna
Language : English
Author: MabryChristian
Language : English
Author: RiebelingTheresa, JamalKunzah, WilsonRebecca, KolbrinkBenedikt, von Samson-HimmelstjernaFriedrich Alexander, MoerkeCaroline, Ramos GarciaLaura, DahlkeEileen, MichelsFriederike, LühderFred, SchunkDomagoj, DoldiPhilipp, TyczynskiBartosz, KribbenAndreas, FlühCharlotte, TheiligFranziska, KunzendorfUlrich, MeierPascal, KrautwaldStefan
Language : English
Author: SchaeferSara M, Vives RodriguezAna, LouisElan D
Language : English
Author: BhaktaJanki, BainbridgeJacquelyn, BorgeltLaura
Language : English
Author: Cabo-LopezI, CannetiB, Puy-NunezA
Language : Spanish
Author: VasconcellosLuiz Felipe R, NassifDaniel, SpitzMariana
Language : English
Author: VeronikiAreti Angeliki, RiosPatricia, CogoElise, StrausSharon E, FinkelsteinYaron, KealeyRyan, ReynenEmily, SoobiahCharlene, ThavornKednapa, HuttonBrian, HemmelgarnBrenda R, YazdiFatemeh, D'SouzaJennifer, MacDonaldHeather, TriccoAndrea C
Language : English
Author: Le DaréBrendan, TriquetLouise, DegremontAdeline, CharbonnelHoel, DefaultAnne, OsmontMarie-Noëlle, PicardSylvie, GentilhommeGuillaume, BellissantEric, ScailteuxLucie-Marie, PolardElisabeth
Language : French
Author: KimYoungjin, LiSheng, PhuntshoSherub, XieMing, ShonHo Kyong, GhaffourNoreddine
Language : English
Author: HeidemannJana, SchmitzBettina, KostevKarel
Language : English
Author: WroblewskiB A, GlennM B, WhyteJ, SingerW D
Language : English
Author: RecsetarMatthew S, FitzsimmonsKevin M, CuelloJoel L, Hoppe-JonesChristiane, SnyderShane A
Language : English
Author: BrunoElisa, NicolettiAlessandra, QuattrocchiGraziella, FilippiniGraziella, ColosimoCarlo, ZappiaMario
Language : English
Author: ZhangManyu, LiWei, HuLan, ChenLi, YangLiu, ZhangTian, ShenHui, PengYanan, GaoShijun, ChenZhibin, WangTan, ZhaoZhenqiang
Language : English
Author: WuXiaoqin, ConkleJeremy L, ErnstFrederick, GanJay
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.